Copyright © 2012 Rolf J. Martin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. W. D. Dietrich, O. Alonso, R. Busto, and D. A. Pelligrino, “Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats,” Stroke, vol. 24, no. 1, pp. 111–116, 1993. View at Scopus
2. G. M. De Courten-Myers, M. Kleinholz, P. Holm et al., “Hemorrhagic infarct conversion in experimental stroke,” Annals of Emergency Medicine, vol. 21, no. 2, pp. 120–126, 1992. View at Scopus
3. G. M. De Courten-Myers, M. Kleinholz, K. R. Wagner, and R. E. Myers, “Fatal strokes in hyperglycemic cats,” Stroke, vol. 20, no. 12, pp. 1707–1715, 1989. View at Scopus
4. R. Prado, M. D. Ginsberg, W. D. Dietrich, B. D. Watson, and R. Busto, “Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories,” Journal of Cerebral Blood Flow and Metabolism, vol. 8, no. 2, pp. 186–192, 1988. View at Scopus
5. N. Kawai, R. F. Keep, and A. L. Betz, “Hyperglycemia and the vascular effects of cerebral ischemia,” Stroke, vol. 28, no. 1, pp. 149–154, 1997. View at Scopus
6. S. E. Capes, D. Hunt, K. Malmberg, P. Pathak, and H. C. Gerstein, “Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview,” Stroke, vol. 32, no. 10, pp. 2426–2432, 2001. View at Scopus
7. H. S. Jørgensen, H. Nakayama, H. O. Raaschou, and T. S. Olsen, “Stroke in patients with diabetes: the Copenhagen stroke study,” Stroke, vol. 25, no. 10, pp. 1977–1984, 1994. View at Scopus
8. C. J. Weir, G. D. Murray, A. G. Dyker, and K. R. Lees, “Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study,” British Medical Journal, vol. 314, no. 7090, pp. 1303–1306, 1997. View at Scopus
9. A. Bruno, J. Biller, H. P. Adams Jr. et al., “Acute blood glucose level and outcome from ischemic stroke,” Neurology, vol. 52, no. 2, pp. 280–284, 1999.
10. M. Kamouchi, T. Matsuki, J. Hata et al., “Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the fukuoka stroke registry,” Stroke, vol. 42, no. 10, pp. 2788–2794, 2011. View at Publisher · View at Google Scholar · View at PubMed
11. J. Putaala, T. Sairanen, A. Meretoja et al., “Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke,” Cerebrovascular Diseases, vol. 31, no. 1, pp. 83–92, 2010. View at Publisher · View at Google Scholar · View at PubMed
12. M. Yong and M. Kaste, “Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial,” Stroke, vol. 39, no. 10, pp. 2749–2755, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. D. A. De Silva, M. Ebinger, S. Christensen et al., “Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial,” Cerebrovascular Diseases, vol. 29, no. 1, pp. 14–21, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. R. N. Auer and B. K. Siesjö, “Biological differences between ischemia, hypoglycemia, and epilepsy,” Annals of Neurology, vol. 24, no. 6, pp. 699–707, 1988. View at Scopus
15. W. A. Pulsinelli, S. Waldman, D. Rawlinson, and F. Plum, “Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat,” Neurology, vol. 32, no. 11, pp. 1239–1246, 1982. View at Scopus
16. S. Rehncrona, I. Rosen, and B. K. Siesjo, “Brain lactic acidosis and ischemic cell damage—I. Biochemistry and neurophysiology,” Journal of Cerebral Blood Flow and Metabolism, vol. 1, no. 3, pp. 297–311, 1981. View at Scopus
17. N. Kawai, R. F. Keep, and A. L. Betz, “Hyperglycemia and the vascular effects of cerebral ischemia,” Stroke, vol. 28, no. 1, pp. 149–154, 1997. View at Scopus
18. R. R. Moustafa and J. C. Baron, “Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery,” British Journal of Pharmacology, vol. 153, no. 1, pp. S44–S54, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
19. L. Allport, T. Baird, K. Butcher et al., “Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring,” Diabetes Care, vol. 29, no. 8, pp. 1839–1844, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
20. C. S. Gray, A. J. Hildreth, P. A. Sandercock et al., “Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK),” Lancet Neurology, vol. 6, no. 5, pp. 397–406, 2007. View at Publisher · View at Google Scholar · View at PubMed
21. M. R. Walters, C. J. Weir, and K. R. Lees, “A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients,” Cerebrovascular Diseases, vol. 22, no. 2-3, pp. 116–122, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
22. A. Szczudlik, A. Slowik, W. Turaj et al., “Transient hyperglycemia in ischemic stroke patients,” Journal of the Neurological Sciences, vol. 189, no. 1-2, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
23. A. A. Wong, P. J. Schluter, R. D. Henderson, J. D. O'Sullivan, and S. J. Read, “Natural history of blood glucose within the first 48 hours after ischemic stroke,” Neurology, vol. 70, no. 13, pp. 1036–1041, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. L. G. Stead, R. M. Gilmore, M. F. Bellolio et al., “Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke,” Neurocritical Care, vol. 10, no. 2, pp. 181–186, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. American Diabetes Association, “Standards of Medical Care in Diabetes—2008,” Diabetes Care, vol. 31, no. 1, supplement, pp. S12–S54, 2008.
26. “Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders: stroke—1989: recommendations on stroke prevention, diagnosis, and therapy,” Stroke, vol. 20, pp. 1407–1431, 1989.
27. B. B. Hamilton, J. A. Laughlin, R. C. Fiedler, and C. V. Granger, “Interrater reliability of the 7-level Functional Independence Measure (FIM),” Scandinavian Journal of Rehabilitation Medicine, vol. 26, no. 3, pp. 115–119, 1994.
28. G. Van Den Berghe, P. Wouters, F. Weekers et al., “Intensive insulin therapy in critically ill patients,” New England Journal of Medicine, vol. 345, no. 19, pp. 1359–1367, 2001. View at Publisher · View at Google Scholar · View at Scopus
29. K. Malmberg, L. Rydén, S. Efendic et al., “Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year,” Journal of the American College of Cardiology, vol. 26, no. 1, pp. 57–65, 1995. View at Publisher · View at Google Scholar · View at Scopus
30. A. G. Pittas, R. D. Siegel, and J. Lau, “Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials,” Journal of Parenteral and Enteral Nutrition, vol. 30, no. 2, pp. 164–172, 2006. View at Publisher · View at Google Scholar · View at Scopus
31. S. H. Kreisel, A. Alonso, K. Szabo, and M. G. Hennerici, “Sugar and NICE—aggressive hyperglycaemic control in ischaemic stroke and what can we learn from non-neurological intensive glucose control trials in the critically ill?” Cerebrovascular Diseases, vol. 29, no. 6, pp. 518–522, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
32. R. Soylemez Wiener, D. C. Wiener, and R. J. Larson, “Benefits and risks of tight glucose control in critically ill adults: a meta-analysis,” Journal of the American Medical Association, vol. 300, no. 8, pp. 933–944, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
33. S. Finfer, R. Bellomi, D. Blair et al., “Intensive versus conventional glucose control in critically Ill patients,” New England Journal of Medicine, vol. 360, no. 13, pp. 1283–1297, 2009. View at Publisher · View at Google Scholar · View at PubMed
34. S. K. Schiemanck, G. Kwakkel, M. W. M. Post, and A. J. H. Prevo, “Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome poststroke: a critical review of the literature,” Neurorehabilitation and Neural Repair, vol. 20, no. 4, pp. 492–502, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus